Eli Lilly’s Lartruvo Gets FDA Accelerated Approval to Treat Soft Tissue Sarcoma
U.S. regulatory authority Food and Drug Administration on 19th October 2016, granted accelerated approval to Eli Lilly’s Lartruvo, a drug
Read more
Clinical Research Society
International Society for Clinical Research and Translational Medicine